These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38190189)

  • 1. Impact of altering the invitation package on screening participation among never-screeners in the Flemish population-based cancer screening programs.
    Kellen E; Meers Z; Pil L; Goossens MC
    Eur J Cancer Prev; 2024 Mar; 33(2):181-184. PubMed ID: 38190189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.
    Radde K; Gottschalk A; Bussas U; Schülein S; Schriefer D; Seifert U; Neumann A; Kaiser M; Blettner M; Klug SJ
    Int J Cancer; 2016 Sep; 139(5):1018-30. PubMed ID: 27083776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
    Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
    BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for increasing women participation in community breast cancer screening.
    Bonfill X; Marzo M; Pladevall M; Martí J; Emparanza JI
    Cochrane Database Syst Rev; 2001; 2001(1):CD002943. PubMed ID: 11279781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies.
    Segnan N; Senore C; Giordano L; Ponti A; Ronco G
    Tumori; 1998; 84(3):348-53. PubMed ID: 9678615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of text messages as an alternative invitation method for breast cancer screening: A randomized controlled trial (M-TICS study).
    Vives N; Vidal C; de Guzman EN; Farre A; Panera JA; Binefa G; Garcia M;
    PLoS One; 2024; 19(8):e0306720. PubMed ID: 39208325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening uptake: A randomized controlled trial assessing the effect of sending invitation letters to non-adherent women combined with sending their general practitioners a list of their non-adherent patients (study protocol).
    Teigné D; Banaszuk AS; Grimault C; Abes L; Gaultier A; Rat C
    Front Public Health; 2022; 10():1035288. PubMed ID: 36438208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing Cervical Cancer Screening Coverage: A Randomised, Community-Based Clinical Trial.
    Acera A; Manresa JM; Rodriguez D; Rodriguez A; Bonet JM; Trapero-Bertran M; Hidalgo P; Sànchez N; de Sanjosé S
    PLoS One; 2017; 12(1):e0170371. PubMed ID: 28118410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake of breast and cervical cancer screening in four Gulf Cooperation Council countries.
    So VHT; Channon AA; Ali MM; Merdad L; Al Sabahi S; Al Suwaidi H; Al Ajeel A; Osman N; Khoja TAM
    Eur J Cancer Prev; 2019 Sep; 28(5):451-456. PubMed ID: 30260812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark.
    Jacobsen KK; von Euler Chelpin M; Vejborg I; Lynge E
    J Med Screen; 2017 Mar; 24(1):20-26. PubMed ID: 27206815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial.
    Montero-Moraga JM; Posso M; Román M; Burón A; Sala M; Castells X; Macià F
    BMC Public Health; 2021 Jul; 21(1):1301. PubMed ID: 34217258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based organized cervical cancer screening pilot program in France.
    Hamers FF; Duport N; Beltzer N
    Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practitioners can increase participation in cervical cancer screening - a model program in Hungary.
    Gyulai A; Nagy A; Pataki V; Tonté D; Ádány R; Vokó Z
    BMC Fam Pract; 2018 May; 19(1):67. PubMed ID: 29778099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators.
    Jidkova S; Hoeck S; Kellen E; le Cessie S; Goossens MC
    BMC Cancer; 2022 Feb; 22(1):183. PubMed ID: 35177021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities.
    Jolidon V; De Prez V; Willems B; Bracke P; Cullati S; Burton-Jeangros C
    BMC Public Health; 2020 Oct; 20(1):1517. PubMed ID: 33028278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.